20 related articles for article (PubMed ID: 29945345)
1. Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy.
Arons E; Sorbara L; Raffeld M; Stetler-Stevenson M; Steinberg SM; Liewehr DJ; Pastan I; Kreitman RJ
Cancer Immunol Immunother; 2006 Sep; 55(9):1100-10. PubMed ID: 16311729
[TBL] [Abstract][Full Text] [Related]
2. Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist.
Hosoya T; Sato-Kaneko F; Ahmadi A; Yao S; Lao F; Kitaura K; Matsutani T; Carson DA; Hayashi T
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6836-E6844. PubMed ID: 29967183
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
[TBL] [Abstract][Full Text] [Related]
4. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.
Zareinejad M; Mehdipour F; Roshan-Zamir M; Faghih Z; Ghaderi A
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835465
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonality of CD8+ T cells in breast cancer patients.
Ito K; Fetten J; Khalili H; Hajdu S; Busch E; Pergolizzi R; Vinciguerra V; Chang MD
Mol Med; 1997 Dec; 3(12):836-51. PubMed ID: 9440117
[TBL] [Abstract][Full Text] [Related]
6. Memory CD4
Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
[TBL] [Abstract][Full Text] [Related]
7. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
8. Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients.
Li Y; Geng S; Du X; Chen S; Yang L; Wu X; Li B; Schmidt CA; Przybylski GK
Hematology; 2011 Jan; 16(1):43-9. PubMed ID: 21269567
[TBL] [Abstract][Full Text] [Related]
9. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans.
Raju R; Navaneetham D; Kellermann SA; Freeman SL; Morris JC; McCormick DJ; Conti-Fine BM
J Autoimmun; 1997 Oct; 10(5):479-89. PubMed ID: 9376076
[TBL] [Abstract][Full Text] [Related]
10. Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public.
Pauza CD; Cairo C
Cell Immunol; 2015 Jul; 296(1):22-30. PubMed ID: 25769734
[TBL] [Abstract][Full Text] [Related]
11. Analysis of T cell receptor repertoire based on Vβ chain in patients with breast cancer.
Faghih Z; Deihimi S; Talei A; Ghaderi A; Erfani N
Cancer Biomark; 2018; 22(4):733-745. PubMed ID: 29945345
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
